A large-scale biomedical database containing genetic and health information from hundreds of thousands of participants.A biobank is an organized collection of biological samples — most often blood, saliva, or tissue — stored together with the health and lifestyle information of the people who donated them. UK Biobank is one of the largest and most detailed of these resources: roughly half a million volunteers from across the United Kingdom agreed to give samples and to have their health followed over many years through links to national medical records. The result is a single, deeply characterized group of people whose genetic makeup, medical history, and eventual diagnoses can be studied together.
What makes such a resource valuable is scale combined with follow-up. Common diseases like diabetes, heart disease, and many cancers arise from hundreds of small genetic influences interacting with environment and behaviour; detecting those influences requires very large numbers of participants, observed for long enough that enough of them develop each condition. A biobank supplies exactly that, and because the data are standardized, findings from one analysis can be checked against another.
UK Biobank has become a standard reference dataset for genetic epidemiology, used to discover risk variants, build polygenic scores, and test whether observed associations hold up in an independent population. It also illustrates the ethical and logistical machinery of modern large-scale research: consent, anonymization, and controlled access for approved scientists.
UK Biobank was established in the mid-2000s, with recruitment of about 500,000 participants between 2006 and 2010, and has since added imaging, genome sequencing, and repeated follow-up visits.
Participants attend an assessment centre where they answer questionnaires, undergo physical measurements, and provide samples. DNA is extracted and genotyped on arrays that read hundreds of thousands to millions of known variable sites in the genome; a subset may also have their whole genomes sequenced. All of this is stored under a pseudonymous identifier.
Long-term health information arrives by linking that identifier to hospital records, cancer registries, and death registries, so researchers can see who develops which disease and when. Approved researchers then query the de-identified data through a secure system, combining genetic, clinical, and lifestyle variables in their analyses without ever seeing participants' identities.
It underpins genome-wide association studies, polygenic risk score development, and epidemiological research on disease risk factors, with data accessed by thousands of researchers worldwide.
UK Biobank participants are followed through their National Health Service records, so a diagnosis made decades after enrolment automatically becomes part of the dataset.